COQ8B
MOLECULAR TARGETcoenzyme Q8B
COQ8B (coenzyme Q8B) is targeted by 12 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting COQ8B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | erlotinib | 5.55 | 256 |
| 2 | sb 203580 | 4.92 | 136 |
| 3 | vandetanib | 4.30 | 73 |
| 4 | sb 202190 | 3.64 | 37 |
| 5 | canertinib | 3.53 | 33 |
| 6 | pelitinib | 3.50 | 32 |
| 7 | bms 387032 | 3.47 | 31 |
| 8 | tae 684 | 3.43 | 30 |
| 9 | fedratinib | 3.40 | 29 |
| 10 | r 406 | 2.83 | 16 |
| 11 | tg100 115 | 2.08 | 7 |
| 12 | Crizotinib | 0.69 | 1 |
About COQ8B as a Drug Target
COQ8B (coenzyme Q8B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 12 compounds with documented COQ8B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
COQ8B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.